Quince Therapeutics Files 8K - Other Events >QNCX
Quince Therapeutics Inc. (QNCX) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on October 09, 2026. On October 7, 2026, the Board approved the termination of the Company's Outside Director Compensation Policy, effective as of October 7, 2026. Effective October 10, 2026, the Company rel